Notch signaling pathway: architecture, disease, and therapeutics

B Zhou, W Lin, Y Long, Y Yang, H Zhang… - Signal transduction and …, 2022 - nature.com
The NOTCH gene was identified approximately 110 years ago. Classical studies have
revealed that NOTCH signaling is an evolutionarily conserved pathway. NOTCH receptors …

New insights into the differentiation of megakaryocytes from hematopoietic progenitors

LJ Noetzli, SL French, KR Machlus - … , thrombosis, and vascular …, 2019 - Am Heart Assoc
Megakaryocytes are hematopoietic cells, which are responsible for the production of blood
platelets. The traditional view of megakaryopoiesis describes the cellular journey from …

[图书][B] Hematology E-Book: Basic Principles and Practice

R Hoffman, EJ Benz, LE Silberstein, H Heslop, J Weitz… - 2022 - books.google.com
Extensively revised, comprehensive content from leading global contributors ensures that
Hematology, 8th Edition, remains your# 1 choice for expert guidance in all areas of this …

[HTML][HTML] Decoding human megakaryocyte development

H Wang, J He, C Xu, X Chen, H Yang, S Shi, C Liu… - Cell stem cell, 2021 - cell.com
Despite our growing understanding of embryonic immune development, rare early
megakaryocytes (MKs) remain relatively understudied. Here we used single-cell RNA …

Runt related transcription factor-1 plays a central role in vessel co-option of colorectal cancer liver metastases

M Rada, A Kapelanski-Lamoureux, S Petrillo… - Communications …, 2021 - nature.com
Colorectal cancer liver metastasis (CRCLM) has two major histopathological growth
patterns: angiogenic desmoplastic and non-angiogenic replacement. The replacement …

The role of Hedgehog and Notch signaling pathway in cancer

R Xia, M Xu, J Yang, X Ma - Molecular Biomedicine, 2022 - Springer
Notch and Hedgehog signaling are involved in cancer biology and pathology, including the
maintenance of tumor cell proliferation, cancer stem-like cells, and the tumor …

Development and application of CRISPR/Cas9 technologies in genomic editing

C Zhang, R Quan, J Wang - Human molecular genetics, 2018 - academic.oup.com
Genomic editing to correct disease-causing mutations is a promising approach for the
treatment of human diseases. As a simple and programmable nuclease-based genomic …

Targeting notch to maximize chemotherapeutic benefits: Rationale, advanced strategies, and future perspectives

N Zhdanovskaya, M Firrincieli, S Lazzari, E Pace… - Cancers, 2021 - mdpi.com
Simple Summary The Notch signaling pathway regulates cell proliferation, apoptosis, stem
cell self-renewal, and differentiation in a context-dependent fashion both during embryonic …

Gene editing of human iPSCs rescues thrombophilia in hereditary antithrombin deficiency in mice

LV Tang, Y Tao, Y Feng, J Ma, W Lin, Y Zhang… - Science Translational …, 2022 - science.org
Hereditary antithrombin deficiency is caused by SERPINC1 gene mutations and
predisposes to recurrent venous thromboembolism that can be life-threatening. Therefore …

[HTML][HTML] Treatment of congenital coagulopathies, from biologic to biotechnological drugs: The relevance of gene editing (CRISPR/Cas)

JA De Pablo-Moreno, A Miguel-Batuecas… - Thrombosis …, 2023 - Elsevier
Congenital coagulopathies have, throughout the history of medicine, been a focus of
scientific study and of great interest as they constitute an alteration of one of the most …